JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 22 No. 4 372-375
© 1981 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrio, J. R.
Right arrow Articles by Kuhl, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrio, J. R.
Right arrow Articles by Kuhl, D. E.

Remote, Semiautomated Production of F-18-Labeled 2-Deoxy-2-Fluoro-D-Glucose

J. R. Barrio, N. S. MacDonald, G. D. Robinson, Jr., A. Najafi, J. S. Cook and D. E. Kuhl

University of California at Los Angeles School of Medicine and Laboratory of Nuclear Medicine and Radiation Biology, Los Angeles, California

Correspondence: For reprints contact: J. R. Barrio, PhD, Div. of Nuclear Medicine, UCLA School of Medicine, Los Angeles, CA 90024.

ABSTRACT

A routine production system for 2-deoxy-2-[18F]fluoro-D-glucose (2-18FDG) for medical use is presented. The method involves the preparation of F-18-labeled F2 by the 20Ne(d,{alpha})18F reaction, subsequent fluorination of 3,4,6-tri-o-acetyl-D-glucal, purification, and hydrolysis of the appropriate diastereoisomer to obtain 2-18FDG. These operations are performed using a completely remote, semiautomatic system. There have been no failures in more than 220 consecutive production runs. Currently, two preparations per day of 15–25 mCi of 2-18FDG are routinely performed, with a radiochemical purity, measured by TLC, in excess of 95% and with less than 1 mR radiation exposure to the chemist. Reaction conditions, operational variables, and systems are described in detail.




This article has been cited by other articles:


Home page
Arch NeurolHome page
M. S. Mega, I. D. Dinov, V. Porter, G. Chow, E. Reback, P. Davoodi, S. M. O'Connor, M. F. Carter, H. Amezcua, and J. L. Cummings
Metabolic Patterns Associated With the Clinical Response to Galantamine Therapy: A Fludeoxyglucose F 18 Positron Emission Tomographic Study
Arch Neurol, May 1, 2005; 62(5): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
T. Schifter, J. M. Hoffman, H. P. Hatten JR, M. W. Hanson, R. E. Coleman, and G. R. DeLong
Neuroimaging in Infantile Autism
J Child Neurol, April 1, 1994; 9(2): 155 - 161.
[Abstract] [PDF]


Home page
ScienceHome page
J Engel Jr, D. Kuhl, and M. Phelps
Patterns of human local cerebral glucose metabolism during epileptic seizures
Science, October 1, 1982; 218(4567): 64 - 66.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1981 by the Society of Nuclear Medicine.